Phenotypic variation in paediatric IBD by age: a multi-centre prospective inception cohort study of the Canadian Children IBD Network.
Aims: Incidence of paediatric IBD in Canada is among the highest worldwide and age of onset may be decreasing. In a multi-centre nation-wide inception cohort study, we examined variation in phenotype of IBD throughout the paediatric age spectrum. Children ≥2y and <17y (A1 age at diagnosis) with new onset IBD were systematically evaluated at sites of the Canadian Children IBD Network. Prospectively recorded phenotypic data were compared between age groups. Among 1092 children (70% Caucasian; 64% CD, 36% UC/IBD-U; median age 13y (IQR 11-15y)), 210 (19%) were diagnosed prior to age 10y (Paris A1a) and 43 (4%) prior to age 6y (VEO-IBD). CD was less common in younger children (42%, 56%, 66%, respectively, of VEO-IBD, A1a; A1b). Colon-only IBD (UC/IBDU or CD-colon) was present in 81% of VEO-IBD and 65% of A1a; ileal disease increased progressively, reaching plateau at age 10y. CD location was ileocolonic (L3) in 53% overall. Ileitis (L1) increased with age (6% of VEO-IBD; 13% of A1a; 21% of A1b), as did stricturing/penetrating CD (4% of A1a; 11% of A1b). At all ages UC was extensive (E3/E4) in >85% and disease activity moderate to severe according to PGA and wPCDAI/PUCAI in >70%. Heights were modestly reduced in CD (mean height z score -0.30±1.23), but normal in UC/IBD-U. Paris classification of age at diagnosis is supported by age-related increases in ileal disease until age 10 years. Other phenotypic features including severity are similar across all ages. Linear growth is less impaired in CD than in historical cohorts, reflecting earlier diagnosis.